Chlorine in PDB 6tuu: Leishmania Infantum RAD51 Surrogate LIRADA10 in Complex with 5,6,7,8- Tetrahydro-2-Naphthoic Acid

The structure of Leishmania Infantum RAD51 Surrogate LIRADA10 in Complex with 5,6,7,8- Tetrahydro-2-Naphthoic Acid, PDB code: 6tuu was solved by T.Pantelejevs, M.Hyvonen, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å)	41.88 / 1.74
Space group	P 1 21 1
Cell size a, b, c (Å), α, β, γ (°)	40.271, 118.976, 83.79, 90, 91.42, 90
R / Rfree (%)	19.6 / 23

The binding sites of Chlorine atom in the Leishmania Infantum RAD51 Surrogate LIRADA10 in Complex with 5,6,7,8- Tetrahydro-2-Naphthoic Acid (pdb code 6tuu). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the Leishmania Infantum RAD51 Surrogate LIRADA10 in Complex with 5,6,7,8- Tetrahydro-2-Naphthoic Acid, PDB code: 6tuu:

Chlorine binding site 1 out of 1 in the Leishmania Infantum RAD51 Surrogate LIRADA10 in Complex with 5,6,7,8- Tetrahydro-2-Naphthoic Acid


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of Leishmania Infantum RAD51 Surrogate LIRADA10 in Complex with 5,6,7,8- Tetrahydro-2-Naphthoic Acid within 5.0Å range: probe atom residue distance (Å) B Occ C:Cl402 b:49.5 occ:1.00 O C:HOH624 2.9 26.5 1.0 N C:GLY141 3.1 40.0 1.0 NZ C:LYS144 3.6 37.5 1.0 O C:HOH544 3.6 53.6 1.0 CA C:GLY141 3.7 38.5 1.0 N C:SER142 3.9 30.3 1.0 C C:PHE140 4.0 44.8 1.0 C C:GLY141 4.1 38.6 1.0 CA C:PHE140 4.1 41.2 1.0 N C:THR145 4.1 21.4 1.0 N C:LYS144 4.1 24.9 1.0 N C:GLY143 4.2 28.3 1.0 O C:GLU139 4.3 40.4 1.0 O C:HOH548 4.3 69.7 1.0 CD1 C:PHE140 4.3 51.6 1.0 OG1 C:THR145 4.4 31.1 1.0 CB C:LYS144 4.5 26.1 1.0 CE C:LYS144 4.5 27.7 1.0 CB C:THR145 4.5 29.4 1.0 O C:HOH577 4.6 38.2 1.0 O C:HOH632 4.6 74.1 1.0 OG C:SER142 4.7 33.4 1.0 O C:HOH640 4.7 44.5 1.0 CG C:PHE140 4.7 47.1 1.0 CE1 C:PHE140 4.7 53.2 1.0 CA C:LYS144 4.7 23.5 1.0 O C:HOH568 4.8 71.3 1.0 C C:GLY143 4.8 28.2 1.0 CA C:GLY143 4.9 27.6 1.0 CG C:LYS144 4.9 36.4 1.0 CA C:SER142 4.9 27.3 1.0 NE2 C:GLN284 5.0 74.4 1.0 C C:LYS144 5.0 24.4 1.0 CA C:THR145 5.0 21.8 1.0 O C:GLY141 5.0 39.2 1.0 CB C:PHE140 5.0 44.3 1.0

P.Brear, T.Pantelejevs, M.Hyvonen. Development of Dedicated Crystallographic Systems For Structure-Guided Drug Discovery To Be Published.